An analysis of the factors involved in acne vulgaris
- Conditions
- Acne vulgaris
- Registration Number
- JPRN-UMIN000019445
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Not provided
1_Individuals who contract diabetes, HIV/AIDS or autoimmune disorders, and hepatitis B or C. 2_Individuals with cuts, lacerations, abrasions, or bruises on the biopsy sites 3_Individuals with tattoos on the biopsy sites. 4_Individuals who participated in other clinical study within 28days. 5_Individuals with allergies (self-reported) to wound dressings and adhesives, latex allergy or allergies towards the local anesthetic. 6_Individuals with any relevant past or present medical history which may affect the study results or may lead to increased risk to the subject in the judgment of the Sub-Investigator. 7_Individuals who use prescription medication or OTC topical medication at the biopsy site(s). 8_Individuals with needle phobia. 9_Individuals with self-reported problems in wound healing and/or disposition to develop extensive scars (keloids, hypertrophic wounds). 10_Individuals who are not prepared to give written informed consent 11_Individuals receiving medical treatment that, in the opinion of the Sub-Investigator, may interfere with this study. 12_Individuals taking medications, that in the opinion of the Sub-Investigator could interfere with this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Collection of skin samples with or without acne vulgaris. Evaluation of the content of sebum secretion and collection of sebum and skin flora.
- Secondary Outcome Measures
Name Time Method